APPLICATION SITE VESICLES side effect
What is APPLICATION SITE VESICLES ?Drugs associated with APPLICATION SITE VESICLES
ABREVA ALTABAX BANANA BENGAY CATAPRES CLIMARA COMMIT DAYTRANA DESENEX DURAGESIC ESTRADERM ESTRADIOL FENTANYL IONSYS MYOZYME NEUPRO NEURONTIN NICODERM NICORETTE NICOTINE NITRO PAIN TIGERAPPLICATION SITE VESICLES : Fentanyl Side Effects Report #5648934-4
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Feb 22, 2008. Male patient, weighting 220.0 lb, was diagnosed with pain, hypertension and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site vesicles, back pain, spinal fusion surgery, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with LORTAB, LISINOPRIL, DOXAZOSIN MESYLATE. Patient was hospitalized. Patient recovered.
APPLICATION SITE VESICLES : Duragesic Side Effects Report #5669544-9
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2008. Female patient, weighting 190.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site vesicles, latex allergy, surgery, treatment noncompliance, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.
APPLICATION SITE VESICLES : Nitro Side Effects Report #5689753-2
Physician from ITALY reported NITRO problem on Mar 19, 2008. Female patient, 96 years of age, was diagnosed with ischaemia and was treated with NITRO. After drug was administered, patient experienced the following problems/side effects: application site vesicles, arrhythmia, cardio-respiratory arrest, . NITRO dosage: unknown. During the same period patient was treated with TAVOR, DEURSIL, LASIX, TIENAM, ANTRA. Patient was hospitalized. Patient died on 02/08/2008.
APPLICATION SITE VESICLES : Climara Side Effects Report #5610146-8
CLIMARA PRO problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 11, 2007. Female patient, 46 years of age, was treated with CLIMARA PRO. After drug was administered, patient experienced the following problems/side effects: application site vesicles, . CLIMARA PRO dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Neupro Side Effects Report #5587827-8
Consumer or non-health professional from UNITED STATES reported NEUPRO problem on Aug 21, 2007. Female patient was diagnosed with parkinson's disease and was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site vesicles, rash erythematous, rash pruritic, . NEUPRO dosage: 6MG/24H,1 IN 1 D,TRANSDERMAL. During the same period patient was treated with ZELAPAR, STALEVO, NAMENDA, SYNTHROID, EVISTA, GALANTAMINE HYDROBROMIDE, FORTEO, GINGER CANDY. Patient recovered.
APPLICATION SITE VESICLES : Altabax Side Effects Report #5511334-1
ALTABAX problem was reported by a Health Professional from UNITED STATES on Sept 27, 2007. Female patient, 54 years of age, was treated with ALTABAX. After drug was administered, patient experienced the following problems/side effects: application site vesicles, blister, . ALTABAX dosage: unknown. During the same period patient was treated with ATACAND HCT, PREMARIN, ZOLOFT. Patient recovered.
APPLICATION SITE VESICLES : Fentanyl Side Effects Report #5502624-7
Physician from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Oct 22, 2007. Female patient, weighting 105.0 lb, was diagnosed with phantom pain and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site vesicles, decubitus ulcer, osteoporotic fracture, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
APPLICATION SITE VESICLES : Abreva Side Effects Report #5462401-2
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, 88 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site vesicles, . ABREVA dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Abreva Side Effects Report #5462695-3
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Feb 23, 2007. Female patient, 82 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site vesicles, . ABREVA dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Banana Side Effects Report #5501417-4
BANANA BOAT SPF problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 28, 2007. Female patient, 54 years of age, weighting 120.0 lb, was diagnosed with tanning and was treated with BANANA BOAT SPF. After drug was administered, patient experienced the following problems/side effects: application site vesicles, photosensitivity reaction, skin exfoliation, . BANANA BOAT SPF dosage: unknown. During the same period patient was treated with SOLARCANE, BENADRYL CREAM, CLARITIN. Patient recovered.
APPLICATION SITE VESICLES : Fentanyl Side Effects Report #5422534-3
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Aug 14, 2007. Female patient, weighting 105.0 lb, was diagnosed with phantom pain and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site vesicles, decubitus ulcer, osteoporotic fracture, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
APPLICATION SITE VESICLES : Duragesic Side Effects Report #5423374-1
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2007. Male patient, weighting 220.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site vesicles, arthritis, inadequate analgesia, poor quality sleep, . DURAGESIC dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Catapres Side Effects Report #5428141-0
Pharmacist from UNITED STATES reported CATAPRES problem on June 21, 2007. Male patient, child 2 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site vesicles, . CATAPRES dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Duragesic Side Effects Report #5674588-7
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Female patient, weighting 130.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: anxiety, application site vesicles, dermatitis contact, haemorrhage, insomnia, nerve injury, neuralgia, pain in extremity, . DURAGESIC dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Duragesic Side Effects Report #5619783-8
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on Jan 29, 2008. Female patient, weighting 300.0 lb, was diagnosed with pain, nausea, epilepsy and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site irritation, application site vesicles, withdrawal syndrome, . DURAGESIC dosage: unknown. During the same period patient was treated with PHENERGAN, TOPAMAX. Patient recovered.
APPLICATION SITE VESICLES : Pain Side Effects Report #5627198-1
PAIN PATCH BACK ASPERCREME problem was reported by a Health Professional from UNITED STATES on Feb 12, 2008. Female patient, weighting 170.0 lb, was diagnosed with back pain and was treated with PAIN PATCH BACK ASPERCREME. After drug was administered, patient experienced the following problems/side effects: application site burn, application site vesicles, pain, . PAIN PATCH BACK ASPERCREME dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Catapres Side Effects Report #5600556-7
Consumer or non-health professional from UNITED STATES reported CATAPRES problem on Jan 03, 2008. Male patient was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site rash, application site vesicles, . CATAPRES dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Duragesic Side Effects Report #5608961-X
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 22, 2008. Female patient, weighting 130.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: anxiety, application site vesicles, haemorrhage, insomnia, nerve injury, neuralgia, pain in extremity, skin lesion, . DURAGESIC dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Catapres Side Effects Report #5543836-6
Pharmacist from UNITED STATES reported CATAPRES problem on Nov 16, 2007. Female patient was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site pruritus, application site vesicles, . CATAPRES dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Duragesic Side Effects Report #5490576-8
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2007. Female patient, weighting 220.0 lb, was diagnosed with rheumatoid arthritis and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site rash, application site vesicles, oedema peripheral, thrombosis, . DURAGESIC dosage: unknown. Patient was hospitalized. Patient recovered.
APPLICATION SITE VESICLES : Abreva Side Effects Report #5461471-5
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Oct 19, 2006. Female patient, 56 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site vesicles, oral herpes, . ABREVA dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Abreva Side Effects Report #5462135-4
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Female patient was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site pain, application site vesicles, oral herpes, . ABREVA dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Abreva Side Effects Report #5462743-0
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Mar 05, 2007. Female patient, 52 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site reaction, application site vesicles, lip swelling, . ABREVA dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Myozyme Side Effects Report #5474472-8
MYOZYME problem was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 13, 2007. Male patient, child 3 years of age, weighting 32.85 lb, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, application site vesicles, aspartate aminotransferase increased, bedridden, blood lactate dehydrogenase increased, bone density decreased, diarrhoea, eczema, gastroenteritis rotavirus, . MYOZYME dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, AMBROXOL, CARDIOLOL, ISOMIL, BIOCAL. Patient was hospitalized and became disabled. Patient recovered.
APPLICATION SITE VESICLES : Estradiol Side Effects Report #5413206-X
Pharmacist from AUSTRALIA reported ESTRADIOL problem on Aug 10, 2007. Female patient was treated with ESTRADIOL. After drug was administered, patient experienced the following problems/side effects: application site irritation, application site vesicles, . ESTRADIOL dosage: unknown. During the same period patient was treated with IRBESARTAN, NORMISON, ATORVASTATIN CALCIUM. Patient recovered.
APPLICATION SITE VESICLES : Estraderm Side Effects Report #5420478-4
ESTRADERM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 16, 2007. Female patient, 49 years of age, was diagnosed with menopause and was treated with ESTRADERM. After drug was administered, patient experienced the following problems/side effects: application site scar, application site vesicles, urticaria, . ESTRADERM dosage: 50MG DAILY. Patient recovered.
APPLICATION SITE VESICLES : Nicoderm Side Effects Report #5426269-2
Consumer or non-health professional from UNITED STATES reported NICODERM CQ problem on Aug 22, 2007. Female patient, 49 years of age, was treated with NICODERM CQ. After drug was administered, patient experienced the following problems/side effects: application site irritation, application site vesicles, cardiac arrest, . NICODERM CQ dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Daytrana Side Effects Report #5452085-1
DAYTRANA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Male patient, child 10 years of age, weighting 84.88 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site vesicles, urticaria, . DAYTRANA dosage: 10 MG, TRANSDERMAL. Patient recovered.
APPLICATION SITE VESICLES : Estraderm Side Effects Report #5381630-X
Pharmacist from UNITED KINGDOM reported ESTRADERM problem on June 28, 2007. Female patient, 49 years of age, was diagnosed with menopause and was treated with ESTRADERM. After drug was administered, patient experienced the following problems/side effects: application site scar, application site vesicles, urticaria, . ESTRADERM dosage: 50MG DAILY. Patient recovered.
APPLICATION SITE VESICLES : Estraderm Side Effects Report #5388960-6
ESTRADERM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 10, 2007. Female patient, 49 years of age, was diagnosed with menopause and was treated with ESTRADERM. After drug was administered, patient experienced the following problems/side effects: application site scar, application site vesicles, urticaria, . ESTRADERM dosage: 50MG DAILY. Patient recovered.
APPLICATION SITE VESICLES : Estraderm Side Effects Report #5381630-X
Pharmacist from UNITED KINGDOM reported ESTRADERM problem on June 28, 2007. Female patient, 49 years of age, was diagnosed with menopause and was treated with ESTRADERM. After drug was administered, patient experienced the following problems/side effects: application site scar, application site vesicles, urticaria, . ESTRADERM dosage: 50MG DAILY. Patient recovered.
APPLICATION SITE VESICLES : Estraderm Side Effects Report #5388960-6
ESTRADERM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 10, 2007. Female patient, 49 years of age, was diagnosed with menopause and was treated with ESTRADERM. After drug was administered, patient experienced the following problems/side effects: application site scar, application site vesicles, urticaria, . ESTRADERM dosage: 50MG DAILY. Patient recovered.
APPLICATION SITE VESICLES : Neurontin Side Effects Report #5655980-3
Consumer or non-health professional from UNITED STATES reported NEURONTIN problem on Feb 25, 2008. Female patient, weighting 160.3 lb, was diagnosed with pain, impaired gastric emptying, abdominal pain and was treated with NEURONTIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, application site burn, application site vesicles, depression, impaired gastric emptying, mood altered, . NEURONTIN dosage: unknown. During the same period patient was treated with FENTANYL, PERCOCET. Patient was hospitalized. Patient recovered.
APPLICATION SITE VESICLES : Ionsys Side Effects Report #5664102-4
IONSYS problem was reported by a Physician from GERMANY on Mar 05, 2008. Female patient, 34 years of age, was diagnosed with arthrodesis, pain and was treated with IONSYS. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site reaction, application site vesicles, . IONSYS dosage: unknown. During the same period patient was treated with CONCOR, NOVALGIN, DEXAMETHASONE, RANTUDIL, MUSARIL, FOLSAN, MOVICOL. Patient recovered.
APPLICATION SITE VESICLES : Desenex Side Effects Report #5616271-X
Physician from UNITED STATES reported DESENEX problem on Jan 29, 2008. Male patient, 54 years of age, weighting 175.0 lb, was diagnosed with tinea pedis and was treated with DESENEX. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site vesicles, hyperhidrosis, hypersensitivity, oedema peripheral, . DESENEX dosage: unknown. During the same period patient was treated with NEXIUM. Patient recovered.
APPLICATION SITE VESICLES : Fentanyl Side Effects Report #5630714-7
FENTANYL TRANSDERMAL SYSTEM problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2008. Female patient, weighting 258.0 lb, was diagnosed with pain, inflammation, restless legs syndrome, type 2 diabetes mellitus and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site irritation, application site vesicles, convulsion, depression, insomnia, memory impairment, migraine, neuralgia, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with DURAGESIC, LORTAB, CELEBREX, REQUIP, ACTOMET. Patient was hospitalized. Patient recovered.
APPLICATION SITE VESICLES : Nicorette Side Effects Report #5636527-4
Consumer or non-health professional from AUSTRALIA reported NICORETTE problem on Feb 05, 2008. Female patient, 30 years of age, was treated with NICORETTE. After drug was administered, patient experienced the following problems/side effects: application site burn, application site erythema, application site vesicles, . NICORETTE dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Tiger Side Effects Report #5638428-4
TIGER BALM ULTRA STRENGTH HAW PAR CORPORATION LTD problem was reported by a Physician from UNITED STATES on Feb 21, 2008. Female patient was diagnosed with analgesia and was treated with TIGER BALM ULTRA STRENGTH HAW PAR CORPORATION LTD. After drug was administered, patient experienced the following problems/side effects: application site burn, application site pain, application site vesicles, dermatitis contact, . TIGER BALM ULTRA STRENGTH HAW PAR CORPORATION LTD dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Nicorette Side Effects Report #5641263-4
Consumer or non-health professional from UNITED STATES reported NICORETTE problem on Apr 18, 2007. Female patient was treated with NICORETTE. After drug was administered, patient experienced the following problems/side effects: application site rash, application site scar, application site vesicles, migraine, pain in jaw, . NICORETTE dosage: unknown. During the same period patient was treated with NICODERM CQ. Patient recovered.
APPLICATION SITE VESICLES : Bengay Side Effects Report #5590674-4
BENGAY PAIN RELIEVING PATCH problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2008. Male patient, 27 years of age, weighting 170.0 lb, was diagnosed with pain in extremity and was treated with BENGAY PAIN RELIEVING PATCH. After drug was administered, patient experienced the following problems/side effects: application site burn, application site scab, application site vesicles, burns second degree, . BENGAY PAIN RELIEVING PATCH dosage: unknown. Patient was hospitalized. Patient recovered.
APPLICATION SITE VESICLES : Catapres Side Effects Report #5595120-2
Health Professional from UNITED STATES reported CATAPRES problem on Dec 27, 2007. Female patient was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site pruritus, application site vesicles, . CATAPRES dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Catapres Side Effects Report #5595145-7
CATAPRES problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2008. Female patient was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site pruritus, application site vesicles, blood pressure increased, constipation, . CATAPRES dosage: unknown. During the same period patient was treated with COZAAR, DIGOXIN, METOPROLOL TARTRATE, HYDROCHLOROTHIAZIDE, COUMADIN. Patient recovered.
APPLICATION SITE VESICLES : Fentanyl Side Effects Report #5608782-8
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Jan 23, 2008. Female patient, weighting 94.01 lb, was diagnosed with cervix carcinoma, thyroid disorder, pain, muscle spasms and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site pruritus, application site vesicles, hyperhidrosis, thyroid disorder, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, SYNTHROID, LORTAB, VALIUM. Patient recovered.
APPLICATION SITE VESICLES : Catapres Side Effects Report #5558653-0
CATAPRES problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2007. Female patient was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site pruritus, application site vesicles, chest pain, pneumonia, . CATAPRES dosage: unknown. During the same period patient was treated with MICARDIS, CARTIA XT. Patient was hospitalized. Patient recovered.
APPLICATION SITE VESICLES : Fentanyl Side Effects Report #5564801-9
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Dec 07, 2007. Female patient, weighting 210.0 lb, was diagnosed with osteoporosis, fibromyalgia, pain and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site pruritus, application site reaction, application site vesicles, diabetes mellitus, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, METHADONE, LASIX. Patient recovered.
APPLICATION SITE VESICLES : Catapres Side Effects Report #5569687-4
CATAPRES problem was reported by a Health Professional from UNITED STATES on Nov 28, 2007. Female patient was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site pruritus, application site vesicles, . CATAPRES dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Neupro Side Effects Report #5587797-2
Physician from UNITED STATES reported NEUPRO problem on Oct 26, 2007. Male patient, 68 years of age, weighting 216.0 lb, was diagnosed with parkinson's disease and was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site pruritus, application site vesicles, . NEUPRO dosage: 2MG/24H,1 IN 1 D,TRANSDERMAL. During the same period patient was treated with ALOCRIL, AMANTADINE, NICOTINE, STALENO, ARTANE. Patient recovered.
APPLICATION SITE VESICLES : Altabax Side Effects Report #5511355-9
ALTABAX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2007. Female patient was diagnosed with impetigo and was treated with ALTABAX. After drug was administered, patient experienced the following problems/side effects: application site irritation, application site scar, application site vesicles, . ALTABAX dosage: unknown. Patient recovered.
APPLICATION SITE VESICLES : Commit Side Effects Report #5517307-7
Consumer or non-health professional from UNITED STATES reported COMMIT problem on Oct 11, 2007. Female patient, 52 years of age, was treated with COMMIT. After drug was administered, patient experienced the following problems/side effects: application site pain, application site urticaria, application site vesicles, cheilitis, swollen tongue, . COMMIT dosage: unknown. During the same period patient was treated with NICODERM CQ. Patient recovered.
APPLICATION SITE VESICLES : Desenex Side Effects Report #5492696-0
DESENEX PRESCRIPTIONS STRENGTH ANTIFPOWER problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2007. Male patient, 54 years of age, weighting 175.0 lb, was diagnosed with tinea pedis and was treated with DESENEX PRESCRIPTIONS STRENGTH ANTIFPOWER. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site vesicles, hyperhidrosis, oedema peripheral, . DESENEX PRESCRIPTIONS STRENGTH ANTIFPOWER dosage: unknown. During the same period patient was treated with NEXIUM. Patient recovered.
APPLICATION SITE VESICLES : Abreva Side Effects Report #5462777-6
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Mar 12, 2007. Female patient, 60 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: acne, application site erythema, application site vesicles, milia, . ABREVA dosage: unknown. Patient recovered.